Yildiz Ahmet, Yildiz Seyma, Toprak Huseyin, Kocas Cuneyt
Ahmet Yildiz, Istanbul University, Institute of Cardiology, Department of Cardiology, Istanbul, Turkey.
Seyma Yildiz, MD. Bezmialem Vakif University, Department of Radiology, Istanbul, Turkey.
Pak J Med Sci. 2018 Nov-Dec;34(6):1341-1346. doi: 10.12669/pjms.346.16031.
The aim of this study was to investigate the relationship between Breast Arterial Calcification (BAC) on mammography and the 10-year fatal Cardiovascular Disease (CVD) risk by using SCORE risk system.
The study was conducted from September 2013 to July 2014. A total of 66 women with BAC and 66 age-matched controls without BAC were analyzed. The groups were compared with respect to demographics, clinical, reproductive, laboratory parameters, and 10-year fatal CVD risk.
The mean ages of the women in the study was 54.0 years (40-85 years). Hypertension, systolic blood pressure, levels of serum total cholesterol and the calculated SCORE risk were higher in the BAC (+) group than in the BAC (-) group (p=0.04, p=0.031, p=0.046, and p=0.038 respectively). Multivariate analysis showed that none of them was independent factor of BAC on mammograms, only the 10-year fatal CVD risk was close to being statistically significant (OR:1.17, CI:0.98-1.38, p=0.06).
BAC on mammography was found to be related to the 10-year fatal CVD risk as calculated by the SCORE risk score system. Additional large-scale prospective studies are required to further assess whether BAC can be considered a useful screening tool for CVD risk prediction in women who screened for breast cancer by mammography.
本研究旨在通过使用SCORE风险系统,调查乳腺钼靶检查中乳腺动脉钙化(BAC)与10年致命心血管疾病(CVD)风险之间的关系。
本研究于2013年9月至2014年7月进行。共分析了66例患有BAC的女性和66例年龄匹配的无BAC对照者。对两组在人口统计学、临床、生殖、实验室参数以及10年致命CVD风险方面进行了比较。
研究中女性的平均年龄为54.0岁(40 - 85岁)。BAC(+)组的高血压、收缩压、血清总胆固醇水平和计算出的SCORE风险均高于BAC(-)组(分别为p = 0.04、p = 0.031、p = 0.046和p = 0.038)。多因素分析显示,这些因素均不是乳腺钼靶检查中BAC的独立因素,只有10年致命CVD风险接近具有统计学意义(OR:1.17,CI:0.98 - 1.38,p = 0.06)。
乳腺钼靶检查中的BAC与通过SCORE风险评分系统计算出的10年致命CVD风险相关。需要进一步开展大规模前瞻性研究,以进一步评估BAC是否可被视为通过乳腺钼靶检查筛查乳腺癌的女性中CVD风险预测的有用筛查工具。